Geir Frode Øy

Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Melanoma

Karine Flem‐Karlsen, Erin McFadden, Nasrin Omar et al. · Molecular Cancer Therapeutics · 2019 · 26 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions

Ana Slipicevic, Geir Frode Øy, Inger Cecilie Askildt et al. · Human Pathology · 2009 · 24 citations

Medicine, Endocrinology, Pathology +9

Biological effects induced by insulin‐like growth factor binding protein 3 (IGFBP‐3) in malignant melanoma

Geir Frode Øy, Ana Slipicevic, Ben Davidson et al. · International Journal of Cancer · 2009 · 22 citations

Medicine, Cancer Biology, Oncology +16

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

Ana Slipicevic, Geir Frode Øy, Anne Katrine Ree Rosnes et al. · Cancer Biology & Therapy · 2013 · 19 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft

Abhilash Pandya, Tore‐Geir Iversen, Siver Andreas Moestue et al. · Nanomaterials · 2021 · 17 citations · Full text

Pharmacy, Oncology, Pharmacology +17